Rabbit Monoclonal E120 To Pkr

Lab Reagents

Human IgG antibody Laboratories manufactures the rabbit monoclonal e120 to pkr reagents distributed by Genprice. The Rabbit Monoclonal E120 To Pkr reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rabbit monoclonal. Other Rabbit products are available in stock. Specificity: Rabbit Category: Monoclonal Group: E120 To

E120 To information

PKR Inhibitor

C4439-25 25 mg
EUR 477.6
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

PKR Inhibitor

C4439-5 5 mg
EUR 164.4
Description: IC50: 186-210 nMPKR Inhibitor is a double-stranded RNA-activated protein kinase (PKR) inhibitor. Initiation of protein synthesis is reported to be regulated by kinase-dependent phosphorylation reactions.

PKR antibody

70R-50271 100 ul
EUR 292.8
Description: Purified Polyclonal PKR antibody

PKR antibody

70R-32462 100 ug
EUR 392.4
Description: Rabbit polyclonal PKR antibody

PKR antibody

70R-32464 100 ug
EUR 392.4
Description: Rabbit polyclonal PKR antibody

PKR antibody

70R-32723 100 ug
EUR 392.4
Description: Rabbit polyclonal PKR antibody

PKR antibody

70R-51622 100 ul
EUR 344.4
Description: Purified Polyclonal PKR antibody

PKR Antibody

49002-100ul 100ul
EUR 399.6

PKR Antibody

49002-50ul 50ul
EUR 286.8

PKR Antibody

3947-002mg 0.02 mg
EUR 206.18
Description: PKR Antibody: The interferon-inducible, double-stranded RNA (dsRNA)-dependent protein kinase PKR is a member of the eukaryotic initiation factor-2 alpha (eIF2-alpha) kinase family, possessing serine-threonine kinase activity and two dsRNA-binding motifs that acts as part of the innate immune system. Upon binding dsRNA, PKR undergoes a conformational change leading to its activation and its phosphorylation of the translation factor eIF2, resulting in a general shutdown of protein synthesis and induction of apoptosis through upregulation of caspase-8 and capsase-9 activity in order to prevent the production of more viruses. To evade the antiviral effects of PKR, viruses have evolved multiple mechanisms, such as the inhibition of PKR by the non-structural protein (NS1) of the influenza virus. More recently, PKR has been implicated in several neurodegenerative diseases including Alzheimer, Huntington, and amyotrophic lateral sclerosis.

PKR Antibody

3947-01mg 0.1 mg
EUR 523.7
Description: PKR Antibody: The interferon-inducible, double-stranded RNA (dsRNA)-dependent protein kinase PKR is a member of the eukaryotic initiation factor-2 alpha (eIF2-alpha) kinase family, possessing serine-threonine kinase activity and two dsRNA-binding motifs that acts as part of the innate immune system. Upon binding dsRNA, PKR undergoes a conformational change leading to its activation and its phosphorylation of the translation factor eIF2, resulting in a general shutdown of protein synthesis and induction of apoptosis through upregulation of caspase-8 and capsase-9 activity in order to prevent the production of more viruses. To evade the antiviral effects of PKR, viruses have evolved multiple mechanisms, such as the inhibition of PKR by the non-structural protein (NS1) of the influenza virus. More recently, PKR has been implicated in several neurodegenerative diseases including Alzheimer, Huntington, and amyotrophic lateral sclerosis.

PKR Peptide

3947P 0.05 mg
EUR 197.7
Description: (CT) PKR peptide

PKR Antibody

3949-002mg 0.02 mg
EUR 206.18
Description: PKR Antibody: The interferon-inducible, double-stranded RNA (dsRNA)-dependent protein kinase PKR is a member of the eukaryotic initiation factor-2 alpha (eIF2-alpha) kinase family, possessing serine-threonine kinase activity and two dsRNA-binding motifs that acts as part of the innate immune system. Upon binding dsRNA, PKR undergoes a conformational change leading to its activation and its phosphorylation of the translation factor eIF2, resulting in a general shutdown of protein synthesis and induction of apoptosis through upregulation of caspase-8 and capsase-9 activity in order to prevent the production of more viruses. To evade the antiviral effects of PKR, viruses have evolved multiple mechanisms, such as the inhibition of PKR by the non-structural protein (NS1) of the influenza virus. More recently, PKR has been implicated in several neurodegenerative diseases including Alzheimer, Huntington, and amyotrophic lateral sclerosis.

PKR Antibody

3949-01mg 0.1 mg
EUR 523.7
Description: PKR Antibody: The interferon-inducible, double-stranded RNA (dsRNA)-dependent protein kinase PKR is a member of the eukaryotic initiation factor-2 alpha (eIF2-alpha) kinase family, possessing serine-threonine kinase activity and two dsRNA-binding motifs that acts as part of the innate immune system. Upon binding dsRNA, PKR undergoes a conformational change leading to its activation and its phosphorylation of the translation factor eIF2, resulting in a general shutdown of protein synthesis and induction of apoptosis through upregulation of caspase-8 and capsase-9 activity in order to prevent the production of more viruses. To evade the antiviral effects of PKR, viruses have evolved multiple mechanisms, such as the inhibition of PKR by the non-structural protein (NS1) of the influenza virus. More recently, PKR has been implicated in several neurodegenerative diseases including Alzheimer, Huntington, and amyotrophic lateral sclerosis.

PKR Peptide

3949P 0.05 mg
EUR 197.7
Description: (NT) PKR peptide

PKR Antibody

24458-100ul 100ul
EUR 468

PKR Antibody

24459-100ul 100ul
EUR 468